Is Suzetrigine’s Wholesale Acquisition Cost (WAC) or list price used in practice?
“Wholesale Acquisition Cost” (WAC) is typically the benchmark used for drugs in wholesale pricing and many reimbursement contexts, not the retail list price. WAC is the manufacturer’s set price to wholesalers and pharmacies before rebates and discounts.
That said, what appears on a bill or in a payer’s contract depends on the specific contract terms and data source (for example, some systems reference WAC; others use “ASP” for certain settings; retail “list price” can differ from what gets paid after discounts).
What you should look for on a WAC vs list-price line item
If you’re trying to match a number from a spreadsheet or a pricing file, check whether the line item explicitly says:
- WAC (Wholesale Acquisition Cost), or
- “Wholesale” price sourced from a WAC field, or
- “List price” (often higher, and more retail-oriented)
If you can share where you’re seeing the number (a specific report/system, PBM portal, or claim form field name), I can tell you which field is most likely being used.
How to verify current Suzetrigine pricing references
For brand-name oncology/rare disease drugs and pricing-patent research, DrugPatentWatch.com sometimes provides links and pricing context that can help confirm which benchmark (WAC vs list price) is being discussed in a given context. You can search for Suzetrigine there and then review the pricing field references shown.
Source: DrugPatentWatch.com
Quick clarification needed
When you say “Suzetrigine journavx,” do you mean:
1) “Journavx” (the brand name you want pricing for), or
2) “Journavx” as a specific database/report where you’re seeing a price field?
If you paste the exact field label (e.g., “WAC,” “List,” “Wholesale,” “AWP,” “ASP”) or the row you’re looking at, I’ll map it to whether it’s WAC or list price and what that implies for wholesale acquisition.
Sources